Raising Our Voices
for Vaccines & Truth
Newsroom
What TIP is saying.
Calendar
Come see us.
Engage
Connect through community.
Advocate
Action is Power!
The Immunization Partnership (TIP) Responds to Today’s HHS Changes to the Childhood Vaccination Schedule
Right now, vaccination protects children in the United States against more than 15 different diseases, based on a schedule designed specifically for our population and health care system—one that differs significantly from the countries this administration has referenced. The Immunization Partnership strongly opposes the decision to weaken the childhood immunization schedule by shifting longstanding routine vaccine recommendations to “shared clinical decision-making,” a move that risks diminishing the leadership role the United States has long played in setting evidence-based public health standards.
Further, a 30-day review followed by an immediate policy change does not meet any reasonable definition of an “exhaustive review,” and dismissing a schedule that has saved countless lives as lacking “gold standard science” insults the generations of scientists and physicians who built it through rigorous, evidence-based processes. Rolling back clear recommendations will lead to more children becoming sick from preventable diseases and undermine public trust in public health rather than strengthen it.
For more information, contact: Darryl Ewing / dewing@immunizeusa.org
The Immunization Partnership (TIP) on Today’s ACIP Vote to Delay the First Dose of the Hepatitis B Vaccine
The Immunization Partnership is alarmed by today’s 8–3 vote by the CDC’s Advisory Committee on Immunization Practices (ACIP) to delay the first dose of the hepatitis B vaccine for many newborns. For more than 30 years, the birth-dose recommendation has been a critical, science-driven safeguard to protect infants from a virus that can cause lifelong illness, liver disease and
death.
Delaying this first dose until two months of age for infants born to mothers who test negative ignores the real-world risks families face. Many mothers do not receive consistent prenatal care, test results can be incomplete or inaccurate, and hepatitis B can still be transmitted through household or caregiver exposure after birth. Removing the universal birth-dose recommendation introduces gaps that put newborns at unnecessary risk — especially in Texas.
TIP urges CDC leadership to fully assess the harmful impact this change could have on infant health and to prioritize policies that keep all children safe. We are also concerned that ACIP arrived at this decision using arguments shaped by misleading information and anecdote rather than the strong scientific evidence that has guided the birth-dose recommendation for more
than 30 years.
For more information, contact: Darryl Ewing / dewing@immunizeusa.org